We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Samuel Urrutia MD

Samuel Urrutia MD

Fellow, Hematology and Oncology, MD Anderson Cancer Center, Houston, TX

Dr. Samuel Urrutia is a fellow in hematology and oncology at the MD Anderson Cancer Center in Houston, Texas. He was awarded his medical degree by the Universidad Nacional Autónoma de Honduras (National Autonomous University of Honduras, Faculty of Medical Science) in Tegucigalpa and underwent residency training in internal medicine at Indiana University in Indianapolis, Indiana. Dr. Urrutia’s professional interests are focused on clonal hematopoiesis, myelodysplasia, and bioinformatics. He is a member of the American College of Physicians and the American Society of Clinical Oncology, among other professional organizations.  

Recent Contributions to PracticeUpdate:

  1. TET2-Mutant Clonal Hematopoiesis and Risk of Gout